Examining Genetic Influence on Response to Beta-Blocker Medications in People With Type 2 Diabetes

NCT00925119 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

31

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Atenolol

Sponsor

University of Maryland, Baltimore

Collaborators

[object Object]